Protein and mRNA markers of ER stress related apoptosis. Cells were treated with BSAconjugated palmitate, oleate, elaidate or vaccenate (800 µM) or with palmitate (800 µM) and oleate, elaidate or vaccenate at a 4:1 or 2:1 molar ratio (200 or 400 µM) at 70-80% confluence for 8 h. (a) cDNA was prepared and CHOP expression was detected by qPCR. GAPDH was used as a constitutive reference gene. Relative expression levels were determined as CHOP/GAPDH ratios. Data are shown as mean values ± S.D.; n = 6; statistically significant differences: * p < 0.05 vs. BSA treated control; ! p < 0.05 vs. palmitate treated samples; # p < 0.05 vs. palmitate and oleate treated cells in case of combinational treatments at the corresponding ratio. (b) Cleaved caspase-3 was detected in cell lysates by Western blot. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a constitutive reference protein. The image shows a typical picture of two independent experiments with two parallels.

Protein and mRNA markers of ER stress related apoptosis. Cells were treated with BSAconjugated palmitate, oleate, elaidate or vaccenate (800 µM) or with palmitate (800 µM) and oleate, elaidate or vaccenate at a 4:1 or 2:1 molar ratio (200 or 400 µM) at 70-80% confluence for 8 h. (a) cDNA was prepared and CHOP expression was detected by qPCR. GAPDH was used as a constitutive reference gene. Relative expression levels were determined as CHOP/GAPDH ratios. Data are shown as mean values ± S.D.; n = 6; statistically significant differences: * p < 0.05 vs. BSA treated control; ! p < 0.05 vs. palmitate treated samples; # p < 0.05 vs. palmitate and oleate treated cells in case of combinational treatments at the corresponding ratio. (b) Cleaved caspase-3 was detected in cell lysates by Western blot. Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a constitutive reference protein. The image shows a typical picture of two independent experiments with two parallels.

Source publication
Article
Full-text available
Trans fatty acids (TFAs) are not synthesized in the human body but are generally ingested in substantial amounts. The widespread view that TFAs, particularly those of industrial origin, are unhealthy and contribute to obesity, cardiovascular diseases and diabetes is based mostly on in vivo studies, and the underlying molecular mechanisms remain to...

Contexts in source publication

Context 1
... an acyl-CoA surplus in FA treated cells may cause alterations in the cellular ceramide content. The sharp contrast, which was seen between the modulation of TG and DG levels, was also observed in relation with TGs and ceramides (Table 4, Figure 7 and Figure S9-columns). The total ceramide content of the cells reached the highest levels (765.3 ± 197.4 ng/mg protein at 4 h and 1 993.9 ± 100.5 ng/mg protein after 8 h) upon palmitate supplementation. ...
Context 2
... values represent a more than 4-fold and 13-fold increase compared to the controls (171.1 ± 12.3 and 149.3 ± 52.4 ng/mg protein, respectively). The accumulating ceramides contained saturated acyl groups, the concentration of palmitoyl-sphingosine (16:0) and stearoyl-sphingosine (18:0) increased parallelly while oleoyl-sphingosine remained near the limit of detection (Figure 7 and Figure S9, Table S8). Table 4. Overall ceramide content of hepatoma cells in lipotoxicity. ...
Context 3
... a single unsaturated FA was added to the cells, palmitoyl-and stearoylsphingosine were consistently unchanged, yet the alteration of unsaturated acyl-sphingosine (ceramide 18:1) depended greatly on the cis or trans nature of the FA. While no significant elevation was found in oleate treated cells, vaccenate induced a 25-fold (4 h) and 18-fold (8 h) elevation and elaidate caused an even higher, 39-fold (4 h) and 25-fold (8 h), increase compared to the control (Figure 7 and Figure S9, Table S8). ...
Context 4
... the moderation of the total ceramide buildup was of nearly the same extent, and TFAs were only slightly less effective than oleate, a remarkable difference was again seen in the production of unsaturated acyl-sphingosine (ceramide 18:1), i.e., these ceramides only appeared in substantial amounts when TFAs were present. Intriguingly, their production seemed to be enhanced by palmitate because the half or quarter dose of a TFA co-administered with palmitate yielded the same or even more of these unusual ceramides as a large dose of the same TFA alone (Figure 7 and Figure S9-line, Table S8). ...
Context 5
... CHOP induction was assessed in our experiments at mRNA level by employing qPCR. A large increase was caused by palmitate while no change could be seen after unsaturated FA administration, either cis or trans (Figure 9a). Oleate helped the cells evade palmitate-induced CHOP induction in combination treatments, particularly at a 2:1 ratio. ...
Context 6
... helped the cells evade palmitate-induced CHOP induction in combination treatments, particularly at a 2:1 ratio. The two TFAs were also protective but to a significantly smaller extent than oleate (Figure 9a). To have a closer look into the activation of apoptosis, we examined the level of cleaved Caspase-3, the major effector caspase governing the process of apoptosis. ...
Context 7
... have a closer look into the activation of apoptosis, we examined the level of cleaved Caspase-3, the major effector caspase governing the process of apoptosis. In accordance with the observed stress signals, palmitate treatment resulted in the most pronounced activation of Caspase-3, while all unsaturated FAs were basically ineffective when applied on their own (Figure 9b). In combination treatments, oleate prevented the cleavage of Caspase-3 at the highest degree in a dose-dependent manner, and the TFAs exerted a similar, albeit milder, effect (Figure 9b). ...
Context 8
... accordance with the observed stress signals, palmitate treatment resulted in the most pronounced activation of Caspase-3, while all unsaturated FAs were basically ineffective when applied on their own (Figure 9b). In combination treatments, oleate prevented the cleavage of Caspase-3 at the highest degree in a dose-dependent manner, and the TFAs exerted a similar, albeit milder, effect (Figure 9b). Protein and mRNA markers of ER stress related apoptosis. ...

Similar publications

Article
Full-text available
Background: Non-alcoholic fatty liver disease (NAFLD) is defined as the most prevalent hepatic disorder that affects a significant population worldwide. There are several genes/proteins, involving in the modulation of NAFLD pathogenesis; sirtuin1 (SIRT1), TP53-inducible regulator gene (TIGAR), and autophagy-related gene 5 (Atg5) are considered a ch...

Citations

... Although oleate clearly decreases the desaturase the level of the enzyme and thus the desaturase activity, there are inconsistent findings with respect to the effect at the mRNA level, and even more so with respect to the promoter activity, suggesting that oleate acts through mRNA and/or protein stabilization rather than reducing transcription 33 . It should be noted that the well-characterized reducing effect of oleate on SCD1 was not seen at all three regulatory levels we examined in HepG2 cells, and the effect of other FAs was also rather modest in this cell line, probably due to the relatively high FA tolerance of HepG2 cells 34 . ...
Article
Full-text available
Overnutrition and genetic predisposition are major risk factors for various metabolic disorders. Stearoyl-CoA desaturase-1 (SCD1) plays a key role in these conditions by synthesizing unsaturated fatty acids (FAs), thereby promoting fat storage and alleviating lipotoxicity. Expression of SCD1 is influenced by various saturated and cis-unsaturated FAs, but the possible role of dietary trans FAs (TFAs) and SCD1 promoter polymorphisms in its regulations has not been addressed. Therefore, we aimed to investigate the impact of the two main TFAs, vaccenate and elaidate, and four common promoter polymorphisms (rs1054411, rs670213, rs2275657, rs2275656) on SCD1 expression in HEK293T and HepG2 cell cultures using luciferase reporter assay, qPCR and immunoblotting. We found that SCD1 protein and mRNA levels as well as SCD1 promoter activity are markedly elevated by elaidate, but not altered by vaccenate. The promoter polymorphisms did not affect the basal transcriptional activity of SCD1. However, the minor allele of rs1054411 increased SCD1 expression in the presence of various FAs. Moreover, this variant was predicted in silico and verified in vitro to reduce the binding of ETS1 transcription factor to SCD1 promoter. Although we could not confirm an association with type 2 diabetes mellitus, the FA-dependent and ETS1-mediated effect of rs1054411 polymorphism deserves further investigation as it may modulate the development of lipid metabolism-related conditions.
... The most advanced trial is of the gemcitabine-elaidate prodrug (CP-4126), which has entered clinical trials for the treatment of pancreatic adenocarcinoma (NCT01124786). However, it is questionable why elaidate was used instead of oleate despite its unfavourable metabolic features and potent stress-induction of trans fatty acids compared to oleate 110 . ...
Article
A low intake of ruminant trans fatty acids in the daily diet of Chinese residents exhibits salutary effects on health.
Article
Dysregulation of lipid metabolism results in metabolism-related diseases. Our previous research indicated that 1.3% E and 4% E ruminant trans fatty acids (R-TFA) caused dyslipidemia and promoted atherosclerotic plaques in ApoE-/- mice, presenting detrimental effects. However, the effect of R-TFA on the lipid metabolism of normal mice remains unclear. Therefore, our current research aims to explore the effects of butter-derived R-TFAs on the lipid metabolism of C57BL/6J mice through the integration of lipidomics and transcriptomics. As a result, we found that 1.3% E butter-derived R-TFA promoted dyslipidemia and impaired hepatic function in C57BL/6J mice fed a high-fat diet, which was associated with an increase in DG (18:1/22:5), TG (18:1/18:2/22:4) and FA (24:5) as determined through lipidomics analysis, but had a less significant effect on C57BL/6J mice fed a low-fat diet. Through a combination analysis and verification of gene expression, we found that the arachidonic acid pathway might be involved in the disruption of lipid metabolism by butter-derived R-TFA. In addition, butter-derived R-TFA up-regulated the expression of unigene thromboxane-A synthase 1 (Tbxas1), arachidonate lipoxygenase 3 (Aloxe3), acyl-coenzyme A thioesterase 2 (Acot2), epoxide hydrolase 2 (Ephx2) and carbonyl reductase 3 (Cbr3) in C57BL/6J mice fed a high-fat diet. Herein, our research provides a new perspective for exploring the effects of butter-derived R-TFA on lipid metabolism and speculates on the possible mechanism of lipid metabolism disorder induced by butter-derived R-TFA in C57BL/6J mice fed a high-fat diet.